PPP1r18 promotes tumor progression in esophageal squamous cell carcinoma by regulating the calcineurin-mediated ERK pathway
Carcinogenesis · 2024
DOI: 10.1093/carcin/bgae028 ↗Kurz gefasst
Fachartikel in der Zeitschrift Carcinogenesis, 2024. Verfasst von Changhao Ren und 7 weiteren Autor:innen. Beteiligte Einrichtung: Department of Thoracic Surgery, Zhongshan Hospital Fudan University, Shanghai 200032, China. Hauptthemen laut MEDLINE: Esophageal Squamous Cell Carcinoma, Calcineurin, Esophageal Neoplasms, Cell Proliferation. Die Arbeit wurde bisher 5-mal zitiert (Crossref) und nennt 49 Literaturangaben. Gefördert von: Science and Technology Commission of Shanghai Municipality.
Abstract (Originalsprache)
Esophageal cancer is one of the most common malignant tumors, and the 5-year overall survival rate is only 20%. Esophageal squamous cell carcinoma (ESCC) is the primary histological type of esophageal carcinoma in China. Protein phosphatase 1 regulatory subunit 18 (PPP1r18) is one of the actin-regulatory proteins and is able to bind to protein phosphatase 1 catalytic subunit alpha (PPP1CA). Yet, little is known about the role of PPP1r18 in ESCC. This study aimed to elucidate the biological functions of PPP1r18 in the ESCC progression. Clinical samples first confirmed that PPP1r18 expression was upregulated in ESCC, and PPP1r18 was correlated with tumor invasion depth, lymph node metastasis, distant metastasis and reduced overall survival. We then observed that PPP1r18 overexpression enhanced cell proliferation in vitro and in vivo. Mechanistically, PPP1r18 regulated tumor progression of ESCC through activating the calcineurin-mediated ERK pathway, rather than binding to PPP1CA. Collectively, our results suggest that PPP1r18 promotes ESCC progression by regulating the calcineurin-mediated ERK pathway. PPP1r18 might be a potential target for the diagnosis and treatment of ESCC.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Substanzen
Autor:innen und Institutionen
- Department of Thoracic Surgery, Zhongshan Hospital Fudan University, Shanghai 200032, China.
- Cancer Center, Zhongshan Hospital, Fudan University, Shanghai 200032, China.
- Department of Endoscopy Center and Endoscopy Research Institute, Zhongshan Hospital, Fudan University, Shanghai, China.
- Department of Endoscopy, Shanghai Collaborative Innovation Center, Shanghai, China.
- Department of Biochemistry and Molecular Biology, School of Basic Medical Sciences, Fudan University, Shanghai, China.
ORCID-Profile: Mingxiang Feng
Förderung
- Science and Technology Commission of Shanghai Municipality
Zitieren
APA
Ren, C., Wu, L., Zhang, S., Qi, K., Zhang, Y., Xu, J., Ruan, Y., & Feng, M. (2024). PPP1r18 promotes tumor progression in esophageal squamous cell carcinoma by regulating the calcineurin-mediated ERK pathway. Carcinogenesis. https://doi.org/10.1093/carcin/bgae028
Vancouver
Ren C, Wu L, Zhang S, Qi K, Zhang Y, Xu J, et al. PPP1r18 promotes tumor progression in esophageal squamous cell carcinoma by regulating the calcineurin-mediated ERK pathway. Carcinogenesis. 2024. doi:10.1093/carcin/bgae028
BibTeX
@article{Ren2024,
author = {Ren, Changhao and Wu, Linfeng and Zhang, Shaoyuan and Qi, Kangwei and Zhang, Yifei and Xu, Jiacheng and Ruan, Yuanyuan and Feng, Mingxiang},
title = {PPP1r18 promotes tumor progression in esophageal squamous cell carcinoma by regulating the calcineurin-mediated ERK pathway},
journal = {Carcinogenesis},
year = {2024},
doi = {10.1093/carcin/bgae028}
}
EUVIMED